Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) announced that first patients have been dosed in new cohorts of two ongoing Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE